Acute Infarct of Myocardium without Coronary Arterial Obstructive Disease in a Patient with Colon Cancer: A Case Report
Main Article Content
Abstract
We report a 40-year-old female with colon cancer, in its first session of treatment with capecitabine/oxaliplatin, who presented an event of acute coronary syndrome type myocardial acute infarction with ST inferior elevation in the first 30 days after initiation of adjuvant treatment, angiographically without lesions and echocardiographically presented impaired ventricular function. This case report illustrates myocardial damage induced by antimetabolites in an acute manner.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Jaya Kanduri J, More L, Godishala A, Asnani A. Fluoropyrimidine- Associated cardiotoxicity. Cardiol Clin 37 (2019) 399–405.
Desai A. et al. Takotsubo cardiomyopathy in cancer patients. Desai et al. Cardio-Oncology (2019) 5:7.
Polk A. et al. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacology and Toxicology 2014, 15:47
Saif. M. Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity. Onco Targets and Therapy 2020:13 10197–10206.
Mrotzek S. et al. Assessment of coronary artery disease during hospitalization for cancer treatment. Clinical Research in Cardiology (2021) 110:200–210.
Iannaccone M. et al. Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy. European Heart Journal: Acute Cardiovascular Care 2018, Vol. 7(7) 631–638.
Bharadwaj A. et al. Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. European Heart Journal (2020) 41, 2183–2193.
Potts J. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. European Heart Journal (2019) 40, 1790–1800.